Synthetic approaches to the microtubule stabilizing agent (-)-laulimalide

Current Opinion in Drug Discovery and Development

Volumn 5, Issue 6, 2002, Pages 944-959

  Crimmins, Michael T ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

( ) laulimalide; Antitumor agent; Asymmetric synthesis; Macrolide; Microtubule stabilizer; Total synthesis

Indexed keywords

ANTINEOPLASTIC AGENT; LAULIMALIDE;

CANCER; DRUG STRUCTURE; DRUG SYNTHESIS; ISOMERISM; METHODOLOGY; MICROTUBULE; REVIEW;

ANIMALS; EXCIPIENTS; HUMANS; MICROTUBULES; PACLITAXEL; TAXOIDS;

EID: 0036868909     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Faulkner JD: Marine natural products. Nat Prod Rep (2002) 19:1-48.
2. Stachel SJ, Biswas K, Danishefsky SJ: The epothilones, eleutherobins, and related types of molecules. Curr Pharm Design (2001) 7:1277-1290.
3. Quinoa E, Kakou Y, Crews P: Fijianolides, polyketide heterocycles from a marine sponge. J Org Chem (1988) 53:3642-3644. Isolation of (-)-laulimalide from Cacospongia mycofijiensis.
4. Corley DG, Herb R, Moore FIE, Scheuer PJ, Paul VJ: Laulimalides: New potent cytotoxic macrolides from a marine sponge and a nudibranch predator. J Org Chem (1988) 53:3644-3646. Isolation of (-)-laulimalide from Hyatella sp.
5. Jefford CW, Bemardinelli G, Tanaka J, Higa T: Structures and absolute configurations of the marine toxins, latrunculin A and laulimalide. Tetrahedron Lett (1996) 37:159-162. Isolation of (-)-laulimalide from Fasciospongia rimosa.
6. Tanaka JI, Higa T, Bemardinelli G, Jefford CW: New cytotoxic macrolides from the sponge Fasciospongia rimosa. Chem Lett (1996):255.
7. Mooberry SL, Tien G, Hernandez AH, Plubrukam A, Davidson BS: Laulimalide and isolaulimalide, new paclitaxel-like microtubule stabilizing agents. Cancer Res (1999) 59:653-660. Biological data on laulimalide's ability to inhibit the growth of tumor cells.
8. Pryor DE, O'Brate A, Bilcer G, Diaz JF, Wang Y, Wang Y, Kabaki M, Jung MK, Andreu JM, Ghosh AK, Giannakakou P, Hamel E: The microtubule stabilizing agent laulimalide does not bind in the taxoid site, kills cells resistant to paclitaxel and epothilones, and may not require its epoxide moiety for activity. Biochemistry (2002) 41:9109-9115. Important data on the binding site of (-)-laulimalide to tubulin and biological data are presented in this paper.
9. Ghosh AK, Wang Y: Total synthesis of (-)-laulimalide. J Am Chem Soc (2000) 122:11027-11028. First total synthesis of (-)-laulimalide.
10. Ghosh AK, Wang Y: A macrolactonization-based strategy to obtain microtuble-stabilizing agent (-)-laulimalide. Tetrahedron Lett (2001) 42:3399-3401.
11. Ghosh AK, Wang Y, Kim JT: Total synthesis of microtubule-stabilizing agent (-)-laulimalide. J Org Chem (2001) 66:8973-8982. Improvements of the onginal Ghosh total synthesis of (-)-laulimalide, including a solution to the problem of isomerization of the 2,3-(Z)-enoate.
12. Paterson I, De Savi C, Tudge M: Total synthesis of the microtubule-stabilizing agent (-)-laulimalide. Org Lett (2001) 3:3149-3152. Total synthesis of (-)-laulimalide using a Mitsunobu macrolactonization.
13. Enev VS, Kaehlig H, Mulzer J: Macrocyclization via allyl transfer: Total synthesis of laulimalide. J Am Chem Soc (2001) 123:10764-10765. Total synthesis of (-)-laulimalide using chiral allylsilane addition to construct the macrolide.
14. Mulzer J, Ohler E: An intramolecular case of Sharpless kinetic resolution: Total synthesis of laulimalide. Angew Chem Int Ed (2001) 40:3842-3846.
15. Wender PA, Hegde SG, Hubbard RD, Zhang L: Total synthesis of (-)-laulimalide. J Am Chem Soc (2002) 124:4956-4957. Total synthesis of (-)-laulimalide using chiral catalyst to execute an allylsilane addition to assemble the two key subunits.
16. Crimmins MT, Stanton MG, Allwein SP: Asymmetric total synthesis of (-)-laulimalide: Exploiting the asymmetric glycolate alkylation reaction. J Am Chem Soc (2002) 124:5958-5959. Total synthesis of laulimalide, demonstrating that the epoxide moeity can be incorporated at an early stage of the synthesis.
17. Mulzer J, Hanbauer M: Total synthesis of the antitumor agent (-)-laulimalide. Tetrahedron Lett (2002) 43:3381-3383.
18. Williams DR, Mi L, Mullins RJ, Stites RE: Synthesis of (-)-laulimalide: An agent for microtubule stabilization. Tetrahedron Lett (2002) 43:4841-4844. Total synthesis of (-)-laulimalide using diastereoselective addition of an allylsilane to an epoxy aldehyde to assemble the two key subunits.
19. 14 segment by a catalytic hetero Diels-Alder strategy. Tetrahedron Lett (1997) 38:2427-2430.
20. 15 segment of antitumor macrolide laulimalide. Tetrahedron Lett (2000) 41:2319-2322.
21. Ghosh AK, Wang Y: Synthetic studies of antitumor macrolide laulimalide: A stereoselective synthesis of the C-17-C-28 segment. Tetrahedron Lett (2000) 41:4705-4708.
22. 16 fragment of the marine toxin, laulimalide. Tetrahedron Lett (1997) 38: 6011-6014.
23. 29 fragment. Synlett (1998) 11:1209-1210.
24. 12-dihydropyran segment of the antitumor agent laulimalide by ring closing metathesis. Tetrahedron Lett (2000) 41:33-36.
25. 15-fragment of laulimalide. Synthesis (2001) 13:2007-2010.
26. 27 fragment of the antitumor agent laulimalide. Tetrahedron Lett (2000) 41:6323-6326.
27. 14-fragment of the antitumor agent laulimalide. Application of Jacobsen's HKR reaction. Synlett (2001) 7:1105-1108.
28. Paterson I, De Savi C, Tudge M: Synthesis of the macrocyclic core of laulimalide. Org Lett (2001) 3:213-216.
29. Lee HW, Jeong CS, Yoon SH, Lee IYC: Synthesis of 3,6-dihydro-2H-pyran subunits of laulimalide using olefinic ring closing metathesis. Part I. Bull Korean Chem Soc (2001) 22:791-792.
30. Lee HW, Yoon SH, Lee IYC, Chung BY: Synthesis of 3,6-dihydro-2H-pyran subunits of laulimalide using olefinic ring closing metathesis. Part II. Bull Korean Chem Soc (2001) 22:1179-1180.
31. 14 fragment. Tetrahedron Lett (2001) 42:797-800.
32. 28 fragment. Tetrahedron Lett (2001) 42:801-803.
33. 28 fragment of laulimalide. Tetrahedron Lett (2002) 43:213-216.
34. 15 segment. Tetrahedron (1995) 51:9413-9436.